Guanfacine

In the US, Guanfacine (guanfacine systemic) is a member of the drug class antiadrenergic agents, centrally acting and is used to treat ADHD and High Blood Pressure.

US matches:

• Guanfacine


• Guanfacine Extended-Release Tablets


• Guanfacine Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02AC02

CAS registry number (Chemical Abstracts Service)

0029110-47-2

Chemical Formula

C9-H9-Cl2-N3-O

Molecular Weight

246

Therapeutic Category

Antihypertensive agent

Chemical Name

Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-

Foreign Names

• Guanfacinum (Latin)
• Guanfacin (German)
• Guanfacine (French)
• Guanfacina (Spanish)

Generic Names

• Guanfacine (OS: BAN, DCF)
• Guanfacine Hydrochloride (OS: BANM, JAN, USAN)
• BS 100-141 (IS)
• LON 798 (IS)
• Guanfacine Hydrochloride (PH: USP 30)

Brand Names

• Estulic
  Novartis, Tunisia



• Guanfacine
  Mylan, United States



• Estulic
  Egis, Hungary; Egis, Russian Federation; Novartis, Belgium; Novartis, Ghana; Novartis, Japan; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe



• Guanfacine HCl
  Actavis, United States; Amneal, United States; Genpharm, United States; Mylan, United States; Watson, United States



• Intuniv
  Shire, United States



• Tenex
  Promius, United States

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.